Hepatocellular cancer: Optimal strategies for screening and surveillance

Digestive Diseases

Volumn 27, Issue 2, 2009, Pages 142-147

  Cabibbo, Giuseppe ^a   Craxì, Antonio ^a  

^a DiBiMIS   (Italy)

Author keywords

Hepatocellular carcinoma; Risk factors; Screening; Surveillance

Indexed keywords

CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER SCREENING; CANCER SIZE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING TEST;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; MASS SCREENING; POPULATION SURVEILLANCE; RISK FACTORS;

EID: 67650938571     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218346     Document Type: Review

References (41)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74108.
2. Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153156.
3. McGlynn KA, Tsao L, Hsing AW, Devesa SS,Fraumeni JF Jr: International trends and patterns of primary liver cancer. Int J Cancer2001;94: 290296.
4. TaylorRobinson SD, Foster GR, Arora S,Hargreaves S, Thomas HC: Increase in primary liver cancer in the UK, 197994. Lancet 1997;350:11421143.
5. ElSerag HB, Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745750.
6. ltekruse SF, McGlynn KA, Reichman ME: Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 200927: 14851491.
7. Fattovich G, Stroffolini T, Zagni I, Donato F:Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology2004;127(suppl 1):S35S50.
8. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, Dash C, Giardiello FM, Glick S, Johnson D, Johnson CD,Levin TR, Pickhardt PJ, Rex DK, Smith RA,Thorson A, Winawer SJ; American CancerSociety Colorectal Cancer Advisory Group;US MultiSociety Task Force; American College of Radiology Colon Cancer Committee:Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US MultiSociety Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 15701595.
9. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma. Hepatology 2005;42:12081236.
10. Parkin DM, Bray FI, Devesa SS: Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37(suppl 8):S4S66.
11. Beasley RP, Hwang LY, Lin CC, et al: Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan.Lancet 1981;2:11291133.
12. Yang HI, Lu SN, Liaw YF, You SL, Sun CA,Wang LY, Hsiao CK, Chen PJ, Chen DS,Chen CJ; Taiwan CommunityBased Cancer Screening Project Group: Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002;347:168174.
13. Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL,Liu CJ, Shih WL, Kao JH, Chen DS, Chen CJ:Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst 2005; 97:265272.
14. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH; REVEALHBV Study Group: Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:6573.
15. ElSerag HB, Mason AC: Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 2000; 160:32273230.
16. Deuffic S, Poynard T, Valleron AJ: Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe. J Viral Hepat 1999;6:411413.
17. Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, Beasley P, Patt YZ: Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002; 36: 12061213.
18. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M, Rizzetto M: Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterol ogy 2002;123:134140.
19. Calle EE, Rodriguez C, WalkerThurmond K, Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003;348:16251638.
20. Bugianesi E: Nonalcoholic steatohepatitis and cancer. Clin Liver Dis 2007;11:191207,xxi.
21. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, ChristensenE, Pagliaro L, Colombo M, Rodes J; EASL Panel of Experts on HCC: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona2000 EASL Conference. European Association for the Study of the Liver. J Hepatol 2001;35:421430.
22. Kudo M, Okanoue T; Japan Society of Hepatology: Management of hepatocellular carcinoma in Japan: consensusbased clinical practice manual proposed by the Japan Society of Hepatology. Oncology 2007; 72(suppl1):215.
23. Trevisani F, D'Intino PE, MorselliLabate AM, Mazzella G, Accogli E, Caraceni P, Do menicali M, De Notariis S, Roda E, BernardiM: Serum afetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti HCV status. J Hepatol 2001;34:570575.
24. Sherman M, Peltekian KM, Lee C: Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepa tology 1995; 22: 432438.
25. Bolondi L, Sofia S, Siringo S, Gaiani S, Casa li A, Zironi G, Piscaglia F, Gramantieri L, Zanetti M, Sherman M: Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a costeffectiveness analysis. Gut2001;48:251259.
26. Thompson Coon J, Rogers G, Hewson P,Wright D, Anderson R, Cramp M, Jackson S,Ryder S, Price A, Stein K: Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. HealthTechnol Assess 2007; 11: 1206.
27. Sheu JC, Sung JL, Chen DS, Yang PM, Lai MY, Lee CS, Hsu HC, Chuang CN, Yang PC, Wang TH, et al: Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 1985;89:259266.
28. Barbara L, Benzi G, Gaiani S, Fusconi F,Zironi G, Siringo S, Rigamonti A, Barbara C,Grigioni W, Mazziotti A, et al: Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992; 16:132137.
29. Trevisani F, De NS, Rapaccini G, Farinati F,Benvegnu L, Zoli M, Grazi GL, Del PP, Di N,Bernardi M; Italian Liver Cancer Group:Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma:effects on cancer stage and patient survival(Italian experience). Am J Gastroenterol2002; 97:734744.
30. Santagostino E, Colombo M, Rivi M, RumiMG, Rocino A, Linari S, Mannucci PM;Study Group of the Association of ItalianHemophilia Centers: A 6month versus a 12month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus. Blood 2003;102:7882.
31. Kim DY, Han KH, Ahn SA, Pik YH, Lee KS,Chon CY, Moon YM: Semiannual surveillance for hepatocellular carcinoma improved patient survival compared to annual surveillance (Korean experience) (abstract). Hepatology 2007; 46(suppl):403A.
32. Trinchet J, Beaugrand M from GRETCH: Arandomized trial comparing 3month vs. 6month screening for HCC by ultrasonography in cirrhosis. Abstracts of the International Liver Cancer Association (ILCA), 2007.
33. Ganne Carrie N, Chastang C, Chapel F, MunzC, Pateron D, Sibony M, Deny P, Trinchet JC,Callard P, Guettier C, Beaugrand M: Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology 1996;23:11121118.
34. Velazquez RF, Rodriguez M, Navascues CA, Linares A, Perez R, Sotorrios NG, Martinez I, Rodrigo L: Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology 2003; 37:520527.
35. Saab S, Ly D, Nieto J, Kanwal F, Lu D, Raman S, Amado R, Nuesse B, Durazo F, Han S,Farmer DG, Ghobrial RM, Yersiz H, Chen P, Schwegel K, Goldstein LI, Tong M, BusuttilRW: Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model. Liver Transpl 2003;9: 672681.
36. Sherman M, Peltekian KM, Lee C: Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepa tology 1995;22:432438.
37. Pateron D, Ganne N, Trinchet JC, Aurousseau MH, Mal F, Meicler C, Coderc E, Re boullet P, Beaugrand M: Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 1994; 20:6571.
38. Sangiovanni A, Del Ninno E, Fasani P, De Fazio C, Ronchi G, Romeo R, Morabito A, De Franchis R, Colombo M: Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 2004; 126:10051014.
39. Zhang BH, Yang BH, Tang ZY: Randomized controlled trial of screening for hepatocel lular carcinoma. J Cancer Res Clin Oncol 2004;130:417422.
40. Stravitz RT, Heuman DM, Chand N, Sterling RK, Shiffman ML, Luketic VA, Sanyal AJ, Habib A, Mihas AA, Giles HC, Maluf DG, Cotterell AH, Posner MP, Fisher RA: Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome. Am J Med 2008;121:119126.
41. Wong GL, Wong VW, Tan GM, Ip KI, Lai WK, Li YW, Mak MS, Lai PB, Sung JJ, Chan HL: Surveillance programme for hepatocel lular carcinoma improves the survival of patients with chronic viral hepatitis. Liver Int2008;28: 7987.